Erwann P Loret

Author PubWeight™ 14.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology 2009 1.15
2 The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J Biol Chem 2004 1.13
3 Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol 2007 1.07
4 HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2005 1.06
5 Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. J Biol Chem 2002 1.00
6 Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. Infect Disord Drug Targets 2012 0.92
7 The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells. J Biol Chem 2005 0.92
8 Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology 2006 0.90
9 Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins. AIDS Res Hum Retroviruses 2010 0.89
10 Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology 2008 0.88
11 Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine 2004 0.87
12 HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells. J Biol Chem 2009 0.85
13 Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Vaccine 2007 0.85
14 A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade. J Biol Chem 2012 0.80
15 Identification of a highly conserved surface on Tat variants. J Biol Chem 2013 0.80